Ceribell (CBLL) Interest & Investment Income (2025 - 2026)
Ceribell (CBLL) posted Interest & Investment Income of -$141000.0 for Q1 2026, down 805.0% on a QoQ basis from $20000.0 in Q4 2025, and down 2250.0% year-over-year from $6558.1 in Q1 2025.
Ceribell (CBLL) Interest & Investment Income (2025 - 2026) Analysis & Trends
Ceribell's Interest & Investment Income history runs 2 years deep, the most recent figure standing at -$141000.0 for Q1 2026.
- Quarterly Interest & Investment Income fell 2250.0% year-over-year to -$141000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24000.0 (changed N/A YoY) and the FY2025 annual result came in at $159000.0, changed N/A from the prior year.
- Interest & Investment Income was -$141000.0 for Q1 2026 at Ceribell, down from $20000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $134000.0 in Q3 2025 and bottomed at -$141000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | Ceribell | 677.56 Mn | 536.38 Mn | 23.12 Mn | -141,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -141,000.00 |
| Dec 31, 2025 | 20,000.00 |
| Sep 30, 2025 | 134,000.00 |
| Jun 30, 2025 | 11,000.00 |
| Mar 31, 2025 | -6,000.00 |